BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 18282123)

  • 1. High-dimensional biology to comprehend hepatocellular carcinoma.
    Vivekanandan P; Singh OV
    Expert Rev Proteomics; 2008 Feb; 5(1):45-60. PubMed ID: 18282123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
    Kurokawa Y; Honma K; Takemasa I; Nakamori S; Kita-Matsuo H; Motoori M; Nagano H; Dono K; Ochiya T; Monden M; Kato K
    Int J Oncol; 2006 Feb; 28(2):383-91. PubMed ID: 16391793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative and integrative functional genomics of HCC.
    Lee JS; Thorgeirsson SS
    Oncogene; 2006 Jun; 25(27):3801-9. PubMed ID: 16799621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hcc-2, a novel mammalian ER thioredoxin that is differentially expressed in hepatocellular carcinoma.
    Nissom PM; Lo SL; Lo JC; Ong PF; Lim JW; Ou K; Liang RC; Seow TK; Chung MC
    FEBS Lett; 2006 Apr; 580(9):2216-26. PubMed ID: 16574106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving 'omics' technologies for diagnostics of head and neck cancer.
    Nagaraj NS
    Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.
    Peng XQ; Wang F; Geng X; Zhang WM
    Expert Rev Proteomics; 2009 Oct; 6(5):551-61. PubMed ID: 19811076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics.
    Santamaría E; Muñoz J; Fernández-Irigoyen J; Prìeto J; Corrales FJ
    Liver Int; 2007 Mar; 27(2):163-73. PubMed ID: 17311610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative genomic classification of human hepatocellular carcinoma].
    Kaposi-Novák P
    Magy Onkol; 2009 Mar; 53(1):61-7. PubMed ID: 19318328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
    Ritorto MS; Borlak J
    J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular classification of hepatocellular carcinoma anno 2011.
    van Malenstein H; van Pelt J; Verslype C
    Eur J Cancer; 2011 Aug; 47(12):1789-97. PubMed ID: 21612914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future of molecular profiling of human hepatocellular carcinoma.
    Roessler S; Budhu A; Wang XW
    Future Oncol; 2007 Aug; 3(4):429-39. PubMed ID: 17661718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.
    Frau M; Biasi F; Feo F; Pascale RM
    Mol Aspects Med; 2010 Apr; 31(2):179-93. PubMed ID: 20176048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic profiling of human hepatocellular carcinoma.
    Lee JS; Thorgeirsson SS
    Semin Liver Dis; 2005; 25(2):125-32. PubMed ID: 15918141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
    El-Aneed A; Banoub J
    Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional genomics of hepatocellular carcinoma.
    Thorgeirsson SS; Lee JS; Grisham JW
    Hepatology; 2006 Feb; 43(2 Suppl 1):S145-50. PubMed ID: 16447291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma.
    Imbeaud S; Ladeiro Y; Zucman-Rossi J
    Semin Liver Dis; 2010 Feb; 30(1):75-86. PubMed ID: 20175035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera.
    Chignard N; Shang S; Wang H; Marrero J; Bréchot C; Hanash S; Beretta L
    Gastroenterology; 2006 Jun; 130(7):2010-22. PubMed ID: 16762624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
    Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular biology and hepatocellular carcinoma: current status and future prospects].
    Saffroy R; Pham P; Lemoine A; Debuire B
    Ann Biol Clin (Paris); 2004; 62(6):649-56. PubMed ID: 15563423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatocellular carcinoma: molecular pathogenesis and novel targets for therapy].
    Marquardt JU; Galle PR; Teufel A
    Dtsch Med Wochenschr; 2012 Apr; 137(16):855-60. PubMed ID: 22495921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.